EAST Stock Overview
EastWest Bioscience Inc., a vertically-integrated wellness company, engages in the manufacturing and sale of hemp nutritional products in Canada and the United States.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
EastWest Bioscience Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.025 |
52 Week High | CA$0.04 |
52 Week Low | CA$0.015 |
Beta | 0.66 |
1 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | 25.00% |
3 Year Change | 25.00% |
5 Year Change | n/a |
Change since IPO | -85.71% |
Recent News & Updates
Shareholder Returns
EAST | CA Pharmaceuticals | CA Market | |
---|---|---|---|
7D | 0% | 14.4% | 0.4% |
1Y | 25.0% | 48.8% | 9.0% |
Return vs Industry: EAST exceeded the Canadian Pharmaceuticals industry which returned -32.9% over the past year.
Return vs Market: EAST exceeded the Canadian Market which returned -0.8% over the past year.
Price Volatility
EAST volatility | |
---|---|
EAST Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 13.2% |
Market Average Movement | 8.5% |
10% most volatile stocks in CA Market | 18.4% |
10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: EAST has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine EAST's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2016 | n/a | Rodney Gelineau | https://www.eastwestbioscience.com |
EastWest Bioscience Inc., a vertically-integrated wellness company, engages in the manufacturing and sale of hemp nutritional products in Canada and the United States. The company also operates Sangster’s Health Center stores that sells supplements and wellness products through its franchise locations and online ecommerce platform. In addition, it is involved in the property management business.
EastWest Bioscience Inc. Fundamentals Summary
EAST fundamental statistics | |
---|---|
Market cap | CA$2.52m |
Earnings (TTM) | CA$108.55k |
Revenue (TTM) | CA$703.10k |
23.2x
P/E Ratio3.6x
P/S RatioIs EAST overvalued?
See Fair Value and valuation analysisEarnings & Revenue
EAST income statement (TTM) | |
---|---|
Revenue | CA$703.10k |
Cost of Revenue | CA$293.78k |
Gross Profit | CA$409.33k |
Other Expenses | CA$300.78k |
Earnings | CA$108.55k |
Last Reported Earnings
Apr 30, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 0.0011 |
Gross Margin | 58.22% |
Net Profit Margin | 15.44% |
Debt/Equity Ratio | 71.7% |
How did EAST perform over the long term?
See historical performance and comparison